Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Monecke

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Rheumatology|April 18, 2020
Bone mineral density in patients with systemic mastocytosis: correlations with clinical and histopathological featuresHans-Jonas Meyer, Wolfram Pönisch, Astrid Monecke, et al.
Anticancer Research|February 5, 2020
Can Diagnostic Low-dose Whole-body CT Reflect Bone Marrow Findings in Systemic Mastocytosis?Hans-Jonas Meyer, Wolfram Pönisch, Astrid Monecke, et al.
Innere Medizin (Heidelberg, Germany)|March 8, 2024
[Combined immunosuppression with cyclosporin A, mycophenolate mofetil (MMF) and dexamethasone for activity control of recurrent secondary hemophagocytic lymphohistiocytosis (sHLH) with underlying systemic lupus erythematosus (SLE)]Modar Saleh, Katja Hampel, Jens Gerth, et al.
Frontiers in Oncology|July 10, 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative studyPhilipp Lückemeier, Aleksandar Radujkovic, Udo Holtick, et al.
Journal of Cancer Research and Clinical Oncology|September 5, 2023
Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutationsChristine E Brambs, Lars-Christian Horn, Ruth Hiller, et al.
Pathology, Research and Practice|May 9, 2024
Mucinous cystadenoma and benign mesonephric-like proliferation in the ovary - Further evidence for clonal relationshipGrit Gesine Ruth Hiller, Anne Kathrin Höhn, Irene Krücken, et al.
Frontiers in Immunology|August 22, 2024
Association of immune evasion in myeloid sarcomas with disease manifestation and patients' survivalMarcus Bauer, Astrid Monecke, Hubert Hackl, et al.
Clinical and Experimental Medicine|June 4, 2025
Personalized drug stratification using endoscopic samples to assess ex vivo gastric cancer tissue susceptibility to chemotherapy and immune checkpoint inhibitorsLaura Hennig, Astrid Monecke, Ngoc Anh Hoang, et al.
Oncoimmunology|August 26, 2021
PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinomaMarlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, et al.
Frontiers in Oncology|February 4, 2022
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case ReportLars Kurch, Thomas W Georgi, Astrid Monecke, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Rheumatology|April 18, 2020
Bone mineral density in patients with systemic mastocytosis: correlations with clinical and histopathological featuresHans-Jonas Meyer, Wolfram Pönisch, Astrid Monecke, et al.
Anticancer Research|February 5, 2020
Can Diagnostic Low-dose Whole-body CT Reflect Bone Marrow Findings in Systemic Mastocytosis?Hans-Jonas Meyer, Wolfram Pönisch, Astrid Monecke, et al.
Innere Medizin (Heidelberg, Germany)|March 8, 2024
[Combined immunosuppression with cyclosporin A, mycophenolate mofetil (MMF) and dexamethasone for activity control of recurrent secondary hemophagocytic lymphohistiocytosis (sHLH) with underlying systemic lupus erythematosus (SLE)]Modar Saleh, Katja Hampel, Jens Gerth, et al.
Frontiers in Oncology|July 10, 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative studyPhilipp Lückemeier, Aleksandar Radujkovic, Udo Holtick, et al.
Journal of Cancer Research and Clinical Oncology|September 5, 2023
Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutationsChristine E Brambs, Lars-Christian Horn, Ruth Hiller, et al.
Pathology, Research and Practice|May 9, 2024
Mucinous cystadenoma and benign mesonephric-like proliferation in the ovary - Further evidence for clonal relationshipGrit Gesine Ruth Hiller, Anne Kathrin Höhn, Irene Krücken, et al.
Frontiers in Immunology|August 22, 2024
Association of immune evasion in myeloid sarcomas with disease manifestation and patients' survivalMarcus Bauer, Astrid Monecke, Hubert Hackl, et al.
Clinical and Experimental Medicine|June 4, 2025
Personalized drug stratification using endoscopic samples to assess ex vivo gastric cancer tissue susceptibility to chemotherapy and immune checkpoint inhibitorsLaura Hennig, Astrid Monecke, Ngoc Anh Hoang, et al.
Oncoimmunology|August 26, 2021
PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinomaMarlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, et al.
Frontiers in Oncology|February 4, 2022
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case ReportLars Kurch, Thomas W Georgi, Astrid Monecke, et al.
Pageof 2